OCUCURE THERAPEUTICS
OcuCure Therapeutics is an ophthalmic pharmaceutical company that develops topical eye drops for the treatment of age-related macular degeneration and diabetic retinopathy diseases. The company was founded in 2005 and is based in Roanoke, Virginia.
OCUCURE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2005-01-01
Address:
Roanoke, Virginia, United States
Country:
United States
Website Url:
http://www.ocucure.com
Total Employee:
1+
Status:
Active
Contact:
5403442966
Email Addresses:
[email protected]
Total Funding:
3.25 M USD
Technology used in webpage:
SPF Apache Amazon PHP PHP 7 Amazon Virginia Region Apache 2.4 OpenSSL CentOS
Similar Organizations
Acuity Medical International
Acuity Medical International, Inc. develops therapeutic devices and protocols for age related macular degeneration to treat adults
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
More informations about "OcuCure Therapeutics"
OcuCure Therapeutics - Crunchbase Company Profile & Funding
OcuCure Therapeutics is an ophthalmic pharmaceutical company that develops topical eye drops for the treatment of age-related macular degeneration and diabetic retinopathy diseases. The …See details»
OcuCure Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
OcuCure Therapeutics, Inc. (Roanoke, VA) has developed a lead compound, known as OC-10X, which is a selective tubulin inhibitor under development for the treatment of Proliferative …See details»
Organization | OcuCure Therapeutics, Inc. - Purdue University
OcuCure Therapeutics, Inc. Report issue. For profit Phase 2. Founded: Roanoke VA United States (2005 ... Organization Overview. First Clinical Trial. 2013 NCT01869933. First …See details»
OcuCure Therapeutics Company Profile 2024: …
OcuCure Therapeutics was founded in 2005. Where is OcuCure Therapeutics headquartered? OcuCure Therapeutics is headquartered in Roanoke, VA. What is the size of OcuCure Therapeutics? OcuCure Therapeutics has 4 total …See details»
OcuCure Therapeutics - VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
OcuCure Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 15 East Salem Avenue Suite 201. Roanoke, Virginia, 24011, United States. 540-344-1106See details»
OcuCure Therapeutics - Contacts, Employees, Board Members
OcuCure Therapeutics develops topical eye drops for the treatment of age-related macular degeneration and diabetic retinopathy. Search Crunchbase. Start Free Trial . Chrome …See details»
OcuCure Therapeutics - Funding, Financials, Valuation & Investors
Organization. OcuCure Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 7. obfuscated. …See details»
OcuCure Therapeutics • UVA Licensing & Ventures Group
OcuCure Therapeutics, Inc. Year Founded: 2005. founders: Milton L. Brown, M.D., Ph.D. address: 15 East Salem Avenue. Suite 201. Roanoke, VA 24011. OcuCure Therapeutics, Inc. is an …See details»
OcuCure Therapeutics | Roanoke, VA, US Startup - Gust
OcuCure Therapeutics is a clinical stage ophthalmic pharma company developing a proprietary topical eye drop to treat both Age-related Macular Degeneration (AMD) and Diabetic …See details»
OC-10X - Drug Targets, Indications, Patents - Synapse - Patsnap
The present study is intended to evaluate the safety and tolerability of topical OC-10X Ophthalmic Suspension in healthy human subjects. OcuCure Therapeutics, Inc. (Roanoke, VA) has …See details»
OcuCure Therapeutics: Developing Novel Eye Drop Treatments
Nov 8, 2006 ROANOKE, Va.--(BUSINESS WIRE)--OcuCure Therapeutics, Inc. is an ophthalmic pharmaceutical company developing novel treatments to prevent vision loss caused by back of …See details»
A Study Assessing Efficacy and Safety of OC-10X in the Treatment …
As demonstrated by OcuCure's preclinical data, tubulin inhibition, using OC-10X, may be a promising new approach to the treatment of PDR and AMD. Like AMD, PDR is a major cause …See details»
Topical Tubulin Inhibition for Exudative AMD - Retina Today
OcuCure Therapeutics, Inc.'s (Roanoke, VA) lead compound, OC-10X, is a selective tubulin inhibitor under development for the treatment of age-related macular degeneration (AMD). …See details»
Organization | OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Report issue. For profit Phase 2. Founded: Roanoke VA United States (2005 ... Organization Overview. First Clinical Trial. 2013 NCT01869933. First …See details»
OC 10X - AdisInsight - Springer
01 Oct 2016 OcuCure Therapeutics terminates a phase II trial in Diabetic retinopathy in Bangladesh (Ophthalmic) (NCT02735369) You need to be a logged in or subscribed to view …See details»
Clinical efficacy of herbal coded formulation ocucure for the ...
Ocucure (Test drug) 500mg two tablets and leutivit (Placebo) 250mg tablets twice daily were prescribed for 6-8 weeks. Presbyopia was improved in 17 patients (28.81%) out of 59 patients …See details»
OcuCure Therapeutics | VentureRadar
OcuCure Therapeutics is an ophthalmic pharmaceutical company developing new proprietary drugs. The company’s lead compound has been formulated as a topical eye drop for both Age …See details»
OCCUR (organization) - Wikipedia
The organization is also involved in raising awareness of and providing medical treatment for HIV/AIDS. [2] History. OCCUR was founded in 1986 as a split of ILGA Japan, founded by …See details»
The Obscure Organization
Jul 8, 2024 The Obscure Organization is a 501(c)(3) non-profit corporation that promotes community and creativity through technology. We provide free resources and training to …See details»